We use some essential cookies to make this website work.
We鈥檇 like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A rapid systematic review that aimed to identify and summarise evidence relating to the effectiveness of antibiotics to treat PVL-SA-associated bacteraemia.
A rapid systematic review that aimed to identify and summarise evidence relating to the effectiveness of antibiotics to treat PVL-SA-associated pneumonia.
This rapid systematic review identified and summarised evidence on strategies to decontaminate settings contaminated by individuals affected by recurrent Staphylococcal skin and soft tissue infection.
This rapid systematic review aimed to identify and summarise available evidence on the effectiveness of decolonisation regimes to prevent recurring or secondary infection with PVL-SA.
皇冠体育app state of health inequalities in the UK, and how UKHSA aims to make health protection fair.
Analysis and learning from radiotherapy and near miss data reported voluntarily by UK radiotherapy providers and the relevant reporting authorities.
Number of laboratory confirmed cases of pertussis in England in 2024 and 2025.
A yearly overview of influenza surveillance results from the winter period.
Report on the uptake of influenza vaccine in children of school age during the 2024 to 2025 influenza vaccination programme in England.
Uptake of the seasonal influenza vaccine in frontline healthcare workers during the 2024 to 2025 influenza vaccination programme in England.
Reports presenting hepatitis B virus surveillance information in different regions of England, 2024 (data to end of 2022).
Antimicrobial resistance alerts (ARAs) inform microbiologists of emerging antimicrobial-resistant micro-organisms that could spread in the UK health service.
Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.
Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in human samples in England.
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Don鈥檛 include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we鈥檇 like to know more about your visit today. .